HLA-C and neoplasm: While the modified TCR is engineered to have a high-affinity interaction with specific major histocompatibility complex (MHC) peptide epitope complexes, CAR-T cells function independently of MHC and incorporate single-chain variable fragments (scFvs) with specificity for tumor-associated antigens.